IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q4 2021 Holdings

Filed 2022-02-14 | 6 holdings | $280.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Amryt Pharma PLCSponsored ADS03217L106$95.7K8,857,26834.1%
Progenity Inc.Note 7.250% 12/074319FAB3$75.4K$103,500,00026.9%
Progenity Inc.COM74319F107$62.4K29,855,84722.2%
Caremax IncCOM CL A14171W103$34.5K4,487,22012.3%
Osmotica Pharmaceuticals PLCSHSG6S41R101$8.8K8,148,8323.1%
Recro Pharma Inc.COM75629F109$3.8K2,202,4201.3%